Did you know?
20% of animal production losses are caused by disease.
75% of emerging infectious diseases
in humans are of animal origin.
80% of medical antibiotic consumption
is in the animal sector, causing antibiotic resistance.
By protecting animal health, we’re preserving our future – and our children’s future.
Our products and workflows for veterinary diagnostics and pathogen research are trusted by lab technicians, vets, and organizations worldwide. Including government agencies, laboratories, research institutes, farmers, and producers.
Personalized Service and support
You're in good hands with us
Benefit from our field application specialists, tailored offerings from our sales team, and our responsive customer care experts.
Together with our partners and customers, we innovate to improve existing technologies, develop new ones, and respond quickly to emerging threats.
WORKING FOR THE FUTURE
To us, sustainability means caring for tomorrow by protecting society, animals, and the environment today.
Improving diagnostics together
We can be reached in countries all over the world, either as INDICAL directly or through our partnerships with local distributors. Since we're nearby, we can improve diagnostics together, no matter where you are.contact us
Culture is key to our success. Fairness, impact, passion and trust are reflected in everything we do.
25 years of proficiency
Founded in 1996 as a veterinary service laboratory and formerly part of QIAGEN, we have a proud and trusted heritage.
LDL is founded as a veterinary service lab in Leipzig, Germany
LDL starts developing and producing its own assays
bactotype qPCR assay product line launched
virotype BVDV RT-PCR workflow launched to improve BVDV diagnostics
pigtype and cattletype ELISA product lines launched
virotype BTV Plus launched – the first real-time Multiplex RT-PCR test kit for veterinary medicine
LDL acquired by QIAGEN – veterinary specific nucleic acid extraction kits launched
virotype ASFV PCR assay launched to reliably identify African Swine Fever Virus
INDICAL BIOSCIENCE is demerged with renewed focus on veterinary diagnostics
Companion animal diagnostics specialist AFOSA joins INDICAL
Swedish veterinary diagnostics pioneer Svanova joins the INDICAL family as INDICAL Sweden AB
INDICAL's parent company Vimian Group is listed on NASDAQ First North
INDICAL is part of Vimian Group – a publicly listed company on Nasdaq Stockholm. Vimian is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health.
The group covers four essential areas within animal health:
Specialty Pharma: www.nextmune.com,
Veterinary Services: www.vetfamily.com,
and diagnostics through INDICAL.
Effective April 2021, Swedish veterinary diagnostics pioneer Svanova joined the INDICAL family and became INDICAL Sweden AB. The SVANOVIR ELISA product range is now available exclusively from INDICAL.
Experienced German producer AFOSA is now part of INDICAL, helping expand our portfolio to improve the welfare of even more animals. INDICAL’s offering now includes ELISA kits for the reliable detection of antibodies to parasitic and vector-transmitted companion animal pathogens.
Chief Financial Officerpeter.firstname.lastname@example.org
Dr Claudia Engemann
Head of R&Dclaudia.email@example.com
Dr Alexander Frey
Chief Strategy Officeralexander.firstname.lastname@example.org
Helen Yuanyuan Cao
COO & Chief Innovation Officerhelen.email@example.com
Dr Fredrik Ullman
CEO (Vimian Group)